Improved outcome of chronic Pseudomonas aeruginosa lung infection is associated with induction of a Th1‐dominated cytokine response
SUMMARY Repeated challenge with antigen is involved in the pathogenesis of a variety of pulmonary diseases. Patients with cystic fibrosis (CF) experience recurrent pulmonary colonization with Pseudomonas aeruginosa before establishment of chronic lung infection. To mimic recurrent lung infections in...
Gespeichert in:
Veröffentlicht in: | Clinical and experimental immunology 2002-02, Vol.127 (2), p.206-213 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | SUMMARY
Repeated challenge with antigen is involved in the pathogenesis of a variety of pulmonary diseases. Patients with cystic fibrosis (CF) experience recurrent pulmonary colonization with Pseudomonas aeruginosa before establishment of chronic lung
infection. To mimic recurrent lung infections in CF patients, the lungs of susceptible
BALB/c mice were re‐infected with P. aeruginosa 14 days after the initial
infection. Singly‐infected BALB/c mice, as well as non‐infected mice, were used as
controls. Decreased mortality and milder lung inflammation in re‐infected BALB/c
mice, as well as a tendency for improved clearance of bacteria, was observed when
compared with singly‐infected mice. The improved outcome in re‐infected mice correlated
with changes in CD4 cell numbers. Surface expression of LFA‐1 on pulmonary CD4 cells
was increased in re‐infected compared with singly‐infected mice. Moreover, resistance
to re‐infection was paralleled by a shift towards a Th1‐dominated response and increased
IL‐12 production. No significant increase in serum IgG was observed in the re‐infected
mice. In conclusion, these results indicate a protective role for a Th1‐dominated
response, independent of antibody production, in chronic P. aeruginosa lung infection in CF. |
---|---|
ISSN: | 0009-9104 1365-2249 |
DOI: | 10.1046/j.1365-2249.2002.01731.x |